Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5177-5185

  Krishnan, L ^a   Sad, S ^a   Patel, G B ^a   Sprott, G D ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARCHAEBACTERIUM; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; IMMUNIZATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0034327288     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5177     Document Type: Article

References (56)

1. Antigen processing and presentation by the class I major histocompatibility complex
2. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
3. + T lymphocytes
4. ISCOMs: An adjuvant with multiple functions
5. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
6. Adjuvant properties of aluminum and calcium compounds
7. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine
8. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen
9. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system
10. Cytokine-containing liposomes as vaccine adjuvants
11. Stability of liposomes prepared from archaeobacterial lipids and phosphatidylcholine mixtures
12. Studies on the permeability and stability of liposomes derived from a membrane-spanning bipolar archaeobacterial tetraether lipid
13. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated and memory responses: Comparison to conventional liposomes and alum
14. Archaeosomes as novel antigen delivery systems
15. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes
16. Lipids of purple membrane from extreme halophiles and methanogenic bacteria
17. Identification of β-L-gulose as the sugar moiety of the main polar lipid Thermoplasma acidophilum
18. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids
19. Formation of unilamellar liposomes from total polar lipid extracts of methanogens
20. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids
21. Induction of soluble protein into the class I pathway of antigen processing and presentation
22. Specific assays for cytokine production by T cells
23. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies
24. Exact prediction of a natural T cell epitope
25. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
26. Uptake of archaeobacterial and conventional liposomes by phagocytic cells
27. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes
28. T cell memory
29. Archaeobacterial lipids: Structure, biosynthesis and function
30. Structures of archaeobacterial membrane lipids
31. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins
32. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes
33. + cytotoxic T cells
34. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb
35. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
36. The role of CpG motifs in innate immunity
37. + cells after a transient response to antigen
38. + cytotoxic T-cell responses during chronic viral infection
39. + T cells
40. + T cell-dependent
41. Cytotoxic T cell responses to DNA vaccination: Dependance on antigen presentation via class II MHC
42. + T cells limits their cytokine synthesis and proliferation
43. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC Class I presentation pathway
44. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
45. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
46. + T helper and a T-killer response
47. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation
48. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages
49. 3)
50. Engineering liposomes for drug delivery: Progress and problems
51. Persistence of memory CD8 T cells in MHC class I-deficient mice
52. Fully mobilizing host defense: Building better vaccines
53. In vivo priming of vires-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
54. Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses
55. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
56. Enumeration of Methanobrevibacter smithii in human feces